PMID: 8954171Jan 1, 1996Paper

Studies on tumor-cell-induced platelet aggregation in human lung cancer cell lines

Journal of Cancer Research and Clinical Oncology
E HeinmöllerH Zirngibl

Abstract

We investigated the ability of human lung cancer cells of different histological subtypes to cause platelet aggregation. Tumor-cell-induced platelet aggregation (TCIPA) was studied in vitro in 13 human lung cancer cell lines [small-cell lung cancer (SCLC), squamous-cell lung cancer, large-cell lung cancer, adenocarcinoma and alveolar-cell lung cancer]. Three tumor cell lines failed to aggregate platelets in platelet-rich plasma, whereas platelet aggregation was induced by 12 cell lines when added to washed platelets and minimal amounts of platelet-poor plasma (0.5% v/v). The thrombin antagonist hirudin inhibited TCIPA in non-small-cell lung cancer cell lines (NSCLC). In SCLC, TCIPA was fully abolished only when the ADP scavenger apyrase was added to hirudin. Thus ADP and thrombin generation by these tumor cell lines are responsible for platelet aggregation. The ability to activate platelets independently of coagulation factors VII and X was demonstrated for 8 cell lines. Electron-microscopically, direct tumor-cell/platelet contact was found to be the initiating mechanism of TCIPA in SCLC, whereas tumor-cell/platelet contacts in NSCLC could only be observed at the peak of the aggregation curve. Lung cancer cells activate platele...Continue Reading

References

Jan 15, 1976·International Journal of Cancer. Journal International Du Cancer·M LieberG Todaro
Nov 11, 1992·International Journal of Cancer. Journal International Du Cancer·R J WeinelS Santoso
Nov 1, 1992·Cancer Metastasis Reviews·V Costantini, L R Zacharski
Nov 1, 1992·Cancer Metastasis Reviews·K V HonnJ D Crissman
Nov 1, 1992·Cancer Metastasis Reviews·Y Q ChenK V Honn
Jan 1, 1991·The Journal of Clinical Investigation·M L NierodzikS Karpatkin
May 1, 1988·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·I M GrossiK V Honn
Jan 1, 1988·Differentiation; Research in Biological Diversity·G BeplerM Haeder
Jan 1, 1987·Journal of Cancer Research and Clinical Oncology·G BeplerK Havemann
May 1, 1973·International Journal of Cancer. Journal International Du Cancer·G J GasicS Murphy
Aug 1, 1994·British Journal of Haematology·H BoukercheJ L McGregor
Aug 1, 1993·The Journal of Clinical Investigation·J P Stone, D D Wagner
Feb 1, 1993·International Journal of Cancer. Journal International Du Cancer·R SeitzK Havemann
Apr 1, 1993·Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis·R SeitzK Havemann
Oct 1, 1995·Scandinavian Journal of Gastroenterology·E HeinmöllerR J Weinel
Dec 1, 1995·Cancer Metastasis Reviews·G L Nicolson, D G Menter

❮ Previous
Next ❯

Citations

May 18, 1999·Thrombosis Research·B OlasT Krajewski
Apr 13, 2013·Surgical Laparoscopy, Endoscopy & Percutaneous Techniques·Guoce CuiHuashan Li
Jul 24, 2004·Anesthesia and Analgesia·Pierre AlbaladejoJean Marty
Feb 26, 2013·European Journal of Internal Medicine·Hadi A GoubranMagdy El-Ekiaby
Jul 16, 2014·Seminars in Oncology·Nick van EsRienk Nieuwland
Jul 16, 2014·Seminars in Oncology·Hadi A GoubranThierry Burnouf
Feb 27, 2016·Thrombosis Research·Soraya MezouarChristophe Dubois
Nov 27, 2004·Asian Journal of Surgery·Karen P L Yap, David R McCready
Aug 8, 2007·Thrombosis Research·María José Santos-MartínezMarek W Radomski
Dec 7, 2013·Hämostaseologie·J RiedlC Ay
Oct 20, 2004·British Journal of Pharmacology·Paul JuraszMarek W Radomski
Nov 30, 2011·Journal of Thrombosis and Haemostasis : JTH·B PsailaI Roberts
Sep 14, 2011·Wiley Interdisciplinary Reviews. Systems Biology and Medicine·Eric M Balzer, Konstantinos Konstantopoulos
Nov 23, 2017·Frontiers in Cardiovascular Medicine·Elizabeth C Lee, Scott J Cameron
Sep 29, 2017·Cancers·Marion LavergnePierre H Mangin
Jun 29, 2016·Oncology Reports·Satoko IshikawaTetsuo Ohta
Jul 7, 2017·Blood·Min Soon ChoVahid Afshar-Kharghan
Jul 29, 2017·Cancer Metastasis Reviews·Marek Z WojtukiewiczKenneth V Honn
Apr 25, 2019·Cancers·Sascha MarxBernhard H Rauch
Aug 17, 2019·Frontiers in Immunology·Ana Luisa Palacios-AcedoLaurence Panicot-Dubois
Apr 9, 2018·Current Treatment Options in Cardiovascular Medicine·Mirela TuzovicEric H Yang
Aug 12, 2020·Journal of Leukocyte Biology·Paula Ribeiro Braga DibEugenio Damaceno Hottz
Oct 28, 2019·International Journal of Molecular Sciences·Claudio A ValenzuelaNelson E Brown
Oct 13, 2020·Frontiers in Oncology·Serena Lucotti, Ruth J Muschel
May 15, 2021·Seminars in Thrombosis and Hemostasis·José Costa, António Araújo
May 4, 2021·Blood·Derrick L TaoOwen J T McCarty
May 4, 2021·Blood·Silvia D'AmbrosiThomas Wurdinger

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.